Nakata T, Shimamoto K, Yonekura S, Kobayashi N, Sugiyama T, Imai K, Iimura O
Second Department of Internal Medicine, School of Medicine, Sapporo Medical University, Japan.
J Nucl Med. 1995 Jun;36(6):1040-2.
In familial amyloidotic polyneuropathy (FAP), the peripheral nervous system is predominantly impaired. Cardiac sympathetic function has not been directly assessed. A 65-yr-old man with severe peripheral neuropathy due to primary systemic amyloidosis was studied. Echocardiograms and scintigraphic examinations with 20Tl and 99mTc-pyrophosphate demonstrated highly thickened but normally perfused left ventricular walls with intense diffuse amyloid deposits. No definite myocardial activity of [123I]metaiodobenzylguanidine (MIBG) was detected in any cardiac region, indicating lack of sympathetic nerve endings. Despite maintained cardiac contractility, left ventricular diastolic performance and heart rate variability assessed by power spectral analysis were markedly depressed. Thus, the myocardial defect of MIBG activity may provide direct evidence of impaired cardiac sympathetic nerve endings due to amyloid deposits in FAP.
在家族性淀粉样多神经病(FAP)中,主要受损的是周围神经系统。心脏交感神经功能尚未得到直接评估。对一名65岁因原发性系统性淀粉样变性导致严重周围神经病变的男性进行了研究。超声心动图以及使用20Tl和99mTc-焦磷酸盐的闪烁扫描检查显示左心室壁高度增厚但灌注正常,有强烈的弥漫性淀粉样沉积物。在任何心脏区域均未检测到[123I]间碘苄胍(MIBG)的明确心肌活性,表明缺乏交感神经末梢。尽管心脏收缩功能得以维持,但通过功率谱分析评估的左心室舒张功能和心率变异性明显降低。因此,MIBG活性的心肌缺陷可能为FAP中淀粉样沉积物导致心脏交感神经末梢受损提供直接证据。